Form 4: Hinge Health Co-Founder Gabriel Mecklenburg Sells Shares

Hinge Health Executive Chairman and Co-Founder Gabriel Mecklenburg sold 83,333 shares of Class A Common Stock via a Rule 10b5-1 trading plan.

Summary

• Executive Chairman and Co-Founder Gabriel Mecklenburg converted 83,333 shares of Class B Common Stock into Class A Common Stock.
• The reporting person subsequently sold all 83,333 converted shares in three separate transactions on May 26, 2026.
• The sales were executed at weighted average prices ranging from $53.31 to $55.21 per share.
• The transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on December 1, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was pre-planned and represents a standard liquidity event for a company founder.

Positives

• The sale was pre-planned under a Rule 10b5-1 trading plan, indicating the transactions were not based on non-public information.
• The reporting person retains significant indirect beneficial ownership of Class B Common Stock through a GRAT and a Family Trust.

Negatives

• The sale represents a divestment of direct holdings by a key company founder and executive.

Risks

• Future sales by insiders could impact market sentiment regarding the company's valuation.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that insider selling via 10b5-1 plans is a standard practice for liquidity and diversification among founders of high-growth technology companies.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for executives to manage equity holdings while avoiding potential insider trading concerns.

Stakeholder Impact

• Shareholders should note the reduction in direct ownership by the Executive Chairman, though significant indirect holdings remain.

Next Steps

• Continued monitoring of future Form 4 filings for additional insider activity.

Key Dates

Keywords

Hinge Health, HNGE, Insider Trading, Form 4, Executive Compensation, Equity Divestment